"Stomach Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the STOMACH.
| Descriptor ID |
D013274
|
| MeSH Number(s) |
C04.588.274.476.767 C06.301.371.767 C06.405.249.767 C06.405.748.789
|
| Concept/Terms |
Stomach Neoplasms- Stomach Neoplasms
- Neoplasm, Stomach
- Stomach Neoplasm
- Neoplasms, Stomach
- Gastric Neoplasms
- Gastric Neoplasm
- Neoplasm, Gastric
- Neoplasms, Gastric
Cancer of Stomach- Cancer of Stomach
- Stomach Cancers
- Gastric Cancer
- Cancer, Gastric
- Cancers, Gastric
- Gastric Cancers
- Stomach Cancer
- Cancer, Stomach
- Cancers, Stomach
- Cancer of the Stomach
|
Below are MeSH descriptors whose meaning is more general than "Stomach Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Stomach Neoplasms".
This graph shows the total number of publications written about "Stomach Neoplasms" by people in this website by year, and whether "Stomach Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 7 | 1 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 5 | 1 | 6 |
| 2007 | 3 | 0 | 3 |
| 2008 | 8 | 0 | 8 |
| 2009 | 2 | 1 | 3 |
| 2010 | 6 | 1 | 7 |
| 2011 | 8 | 1 | 9 |
| 2012 | 6 | 1 | 7 |
| 2013 | 8 | 0 | 8 |
| 2014 | 7 | 0 | 7 |
| 2015 | 6 | 0 | 6 |
| 2016 | 6 | 1 | 7 |
| 2017 | 11 | 1 | 12 |
| 2018 | 5 | 1 | 6 |
| 2019 | 9 | 2 | 11 |
| 2020 | 10 | 3 | 13 |
| 2021 | 8 | 0 | 8 |
| 2022 | 7 | 0 | 7 |
| 2023 | 8 | 0 | 8 |
| 2024 | 10 | 2 | 12 |
| 2025 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.
-
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise. Gut. 2025 Nov 10; 74(12):1949-1961.
-
Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance. Endoscopy. 2025 Oct; 57(10):1118-1127.
-
Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing. JCO Precis Oncol. 2025 Jun; 9:e2400620.
-
Gastric Polyposis and Cancer in Western Patients With Familial Adenomatous Polyposis: Epidemiology, Detection, and Management. J Natl Compr Canc Netw. 2025 Jun; 23(6).
-
Upper GI polyposis and cancer in FAP: diagnosis, surveillance and treatment. Fam Cancer. 2025 May 26; 24(2):49.
-
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics. 2025; 15(13):6444-6453.
-
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 05; 23(5):169-191.
-
Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis. Biochim Biophys Acta Mol Basis Dis. 2025 Aug; 1871(6):167858.
-
Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer. J Natl Compr Canc Netw. 2025 04; 23(4).
-
Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan. Gastric Cancer. 2025 Mar; 28(2):294-300.